RENNIE; Paul S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for RENNIE; Paul S..The latest application filed is for "myc-max inhibitor compound therapeutics for cancer treatment, methods and uses associated therewith".

Company Profile

2.16.13

RENNIE; Paul S. - Richmond CA
RENNIE; Paul S. - Vancouver CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Myc-max Inhibitor Compound Therapeutics For Cancer Treatment, Methods And Uses Associated Therewith App 20220112157 - TCHERKASSOV; Artem ; et al.	2022-04-14
Ar-v7 Inhibitors App 20200031848 - BAN; Fuqiang ; et al.	2020-01-30
Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides Grant 9,095,602 - Gleave , et al. August 4, 2	2015-08-04
TRPM-2 antisense therapy Grant 9,074,209 - Gleave , et al. July 7, 2	2015-07-07
Trpm-2 Antisense Therapy App 20140100261 - Gleave; Martin ; et al.	2014-04-10
TRPM-2 antisense therapy Grant 8,536,149 - Gleave , et al. September 17, 2	2013-09-17
Chemo- And Radiation-sensitization Of Cancer By Antisense Trpm-2 Oligodeoxynucleotides App 20130143944 - Gleave; Martin ; et al.	2013-06-06
Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides Grant 8,361,981 - Gleave , et al. January 29, 2	2013-01-29
Trpm-2 Antisense Therapy App 20120322850 - Gleave; Martin ; et al.	2012-12-20
TRPM-2 antisense therapy Grant 8,173,615 - Gleave , et al. May 8, 2	2012-05-08
TRPM-2 Antisense Therapy App 20110021603 - GLEAVE; MARTIN ; et al.	2011-01-27
TRPM-2 antisense therapy Grant 7,732,422 - Gleave , et al. June 8, 2	2010-06-08
Chemo- and Radiation-sensitization of Cancer by Antisense TRPM-2 Oligodeoxynucleotides App 20090258089 - Gleave; Martin ; et al.	2009-10-15
TRPM-2 antisense therapy Grant 7,592,323 - Gleave , et al. September 22, 2	2009-09-22
Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides Grant 7,569,551 - Gleave , et al. August 4, 2	2009-08-04
TRPM-2 antisense therapy Grant 7,534,773 - Gleave , et al. May 19, 2	2009-05-19
TRPM-2 antisense therapy Grant 7,368,436 - Gleave , et al. May 6, 2	2008-05-06
TRPM-2 Antisense Therapy App 20080064651 - Gleave; Martin ; et al.	2008-03-13
Antisense insulin-like growth factor binding protein (IGFBP)-2-oligodeoxynucleotides for prostate and other endocrine tumor therapy Grant 7,196,067 - Gleave , et al. March 27, 2	2007-03-27
TRPM-2 antisense therapy using an oligonucleotide having 2'-O-(2-methoxy)ethyl modifications Grant 6,900,187 - Gleave , et al. May 31, 2	2005-05-31
Antisense insulin-like growth factor binding protein (igfbp)-2-oligodeoxynucleotides for prostate and other endocrine tumor therapy App 20040072776 - Gleave, Martin ; et al.	2004-04-15
TRPM-2 antisense therapy using an oligonucleotide having 2'-O-(2-methoxy)ethyl modifications App 20030166591 - Gleave, Martin ; et al.	2003-09-04
Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides App 20030158130 - Gleave, Martin ; et al.	2003-08-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.